LAURA MILLNS: Open Payments
NPI 1124334479 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,006 in 84 payments from 21 companies in 2025. Trend: 2023 $3,494 · 2024 $2,643 · 2025 $2,006
Food & beverage: $2,006
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 16 | $419 |
| UCB, Inc. | 10 | $305 |
| ABBVIE INC. | 19 | $299 |
| REVANCE THERAPEUTICS, INC. | 1 | $142 |
| Novartis Pharmaceuticals Corporation | 3 | $130 |
| Journey Medical Corporation | 2 | $113 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Organon LLC | 7 | $63 |
| PFIZER INC. | 3 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
Products named: SOFDRA, Bimzelx, RINVOQ, DAXI, DUPIXENT, Rhapsido, SKYRIZI, VTAMA.
Industry payments across FL — which companies pay providers there.
